In conclusion, the AD-RAI can be used as a prognostic imaging marker in patients with MCI carrying the APOE-ε4 allele, and can accurately and effectively predict the risk of progression to AD in both patients with MCI carrying APOE-ε4 and those without APOE-ε4. The gene discussed is APOE; the disease is Alzheimer disease.